glp 1 meds and alzheimer's GLP-1 Microdosing, Brain Health & Prevention GLP-1 Agonists: Obesity & Alzheimer's

Lau D (2024) In HFpEF with obesity, semaglutide improved health status and weight loss at 52 wk, regardless of initial health status

95% CI, 1.23-1.52), and cardiologists were more likely than other attending health care professionals to prescribe a novel diabetes medication (OR = 1.47

Many patients and clinicians report that Zepbounds nausea is less persistent, though it still occurs during titration

In this setup, companies can add 9amHealth as a benefit, giving employees access to expert care, meds delivered to their door, at-home lab tests, and real support from doctors and specialists

Can a Glucagon-like peptide-1 (GLP-1) receptor agonist be prescribed to a patient with a history of non-medullary thyroid cancer?

Obesity is a complex disease that is closely connected to other serious conditions, including liver disease, type 2 diabetes and cardiovascular disease